BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10831593)

  • 1. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.
    Takeuchi T; Harris JL; Huang W; Yan KW; Coughlin SR; Craik CS
    J Biol Chem; 2000 Aug; 275(34):26333-42. PubMed ID: 10831593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis.
    Seitz I; Hess S; Schulz H; Eckl R; Busch G; Montens HP; Brandl R; Seidl S; Schömig A; Ott I
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):769-75. PubMed ID: 17255532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.
    Yasuda S; Morokawa N; Wong GW; Rossi A; Madhusudhan MS; Sali A; Askew YS; Adachi R; Silverman GA; Krilis SA; Stevens RL
    Blood; 2005 May; 105(10):3893-901. PubMed ID: 15701722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors.
    Yamasaki Y; Satomi S; Murai N; Tsuzuki S; Fushiki T
    J Nutr Sci Vitaminol (Tokyo); 2003 Feb; 49(1):27-32. PubMed ID: 12882393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-urokinase-type plasminogen activator is a substrate for hepsin.
    Moran P; Li W; Fan B; Vij R; Eigenbrot C; Kirchhofer D
    J Biol Chem; 2006 Oct; 281(41):30439-46. PubMed ID: 16908524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells.
    Bhatt AS; Takeuchi T; Ylstra B; Ginzinger D; Albertson D; Shuman MA; Craik CS
    Biol Chem; 2003 Feb; 384(2):257-66. PubMed ID: 12675519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
    Kara E; Manna D; Løset GÅ; Schneider EL; Craik CS; Kanse S
    Thromb Haemost; 2017 Aug; 117(9):1750-1760. PubMed ID: 28726978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificity of the Escherichia coli outer membrane protease OmpT.
    McCarter JD; Stephens D; Shoemaker K; Rosenberg S; Kirsch JF; Georgiou G
    J Bacteriol; 2004 Sep; 186(17):5919-25. PubMed ID: 15317797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase.
    Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K
    Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
    Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
    Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase.
    Friedrich R; Fuentes-Prior P; Ong E; Coombs G; Hunter M; Oehler R; Pierson D; Gonzalez R; Huber R; Bode W; Madison EL
    J Biol Chem; 2002 Jan; 277(3):2160-8. PubMed ID: 11696548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of peptidic inhibitors by target protease is caused by peptide conformational transition.
    Jiang L; Oldenburg E; Kromann-Hansen T; Xu P; Jensen JK; Andreasen PA; Huang M
    Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2017-2023. PubMed ID: 29959058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
    Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
    Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
    Camerer E; Huang W; Coughlin SR
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
    Gong Y; Kim SO; Felez J; Grella DK; Castellino FJ; Miles LA
    J Biol Chem; 2001 Jun; 276(22):19078-83. PubMed ID: 11264290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue.
    Takeuchi T; Shuman MA; Craik CS
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11054-61. PubMed ID: 10500122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.
    Okumura Y; Hayama M; Takahashi E; Fujiuchi M; Shimabukuro A; Yano M; Kido H
    Biochem J; 2006 Dec; 400(3):551-61. PubMed ID: 16872279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease.
    Lee SL; Dickson RB; Lin CY
    J Biol Chem; 2000 Nov; 275(47):36720-5. PubMed ID: 10962009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway.
    Bhatt AS; Welm A; Farady CJ; Vásquez M; Wilson K; Craik CS
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5771-6. PubMed ID: 17389401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain.
    Hinzmann B; Wernicke D; Pfeifer M; Zacharias U; Fischer B; Eisenmenger F; Will H
    Eur J Biochem; 1993 Apr; 213(1):437-43. PubMed ID: 8386628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.